Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2026-01-09 @ 5:12 AM
Study NCT ID:
NCT00198133
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2005-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Sponsor:
Patrick Joseph Loehrer Sr.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
None
Study First Post Date:
2005-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-16
Results First Submit QC Date:
None
Results First Post Date:
2016-01-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-08
Last Update Post Date:
2019-07-22
Last Update Post Date Type:
ACTUAL